Foundation Medicine, Inc.
Boston, MA
- UEI
- EHXPZ92G4AD1
- CAGE
- 73CG0
- Primary NAICS
- 621511 Medical Laboratories
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
-
- 621511 Medical Laboratories Primary
- Corporate family
-
-
Foundation Medicine, Inc.
EHXPZ92G4AD1
- Bioveris Corporation YCFMJNG31TN3
- Genentech Inc. F7F8GZXL7Q93
- Genentech Usa, Inc. SA85BMHCTXK5
- Hoffmann-La Roche Inc. J28SZXJLMNB8
- Intermune, Inc. FSJ4VFEVB5Q7
- Kapa Biosystems, Inc. ESP3ABJZP433
- Roche Diabetes Care Inc. F6JDDN8L9JM4
- Roche Diagnostics Asia Pacific PTE LTD JWKEHKFXAB28
- Roche Diagnostics Corporation JDMDFEZBYH36
- Roche Diagnostics GMBH NZKVNV4ELZM4
- Roche Diagnostics K.K. NTU7TDTQBCZ5
- Roche Diagnostics Operations, Inc. JJTLMFNTGKF4
- Roche Diagnostics S.P.A. CRBLKCZC9XC6
- Roche Health Solutions Inc. YLL7KTH6P9C6
- Roche Laboratories Inc. LUKLLJTL2S86
- Roche Molecular Systems, Inc. XML8DAL97854
- Roche Nimblegen Inc. QF1UC7LVHM99
-
Foundation Medicine, Inc.
EHXPZ92G4AD1
- SAM.gov registration date
- Physical address
- 400 Summer St, Boston, MA 02210, USA
- Website
- foundationmedicine.com
- Founded
- 2010
- Employees
- 251-1K
- Estimated annual revenue
- $100M-$250M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Hematologic malignancies testing | Veterans Integrated Service Network 10 | $67,300 | |
| Task order for tumor molecular testing. | Headquarters | $22,000,000 | |
| :testing | Veterans Integrated Service Network 10 | $237,400 | |
| Modification P1 to add an additional POC for FMI and additional report | Headquarters | $21,581,260 | |
| Hematologic malignancy next generation sequencing (NSG) emergency | Veterans Integrated Service Network 10 | $110,000 |
About Foundation Medicine, Inc.
Foundation Medicine, Inc., a foreign-owned for-profit corporation headquartered in Boston, Massachusetts, delivers comprehensive genomic profiling and next-generation sequencing testing services to the Department of Veterans Affairs as a prime contractor (100% of awards), competing on full-and-open solicitations with no set-aside designations. The company operates as a standalone prime across all federal awards; it performs no subcontract work and engages no subcontractors on its federal contracts.
Foundation Medicine's federal footprint is nearly entirely concentrated with the Veterans Affairs system. The Department of Veterans Affairs Headquarters accounts for 12 awards worth $620.7 million in combined potential value — 100% of the portfolio's dollar concentration — anchored by a single-award Indefinite Delivery Contract (36C10G19D0032) valued at $130.7 million through September 2028 for the VA's National Precision Oncology Program. Under this IDC, Foundation Medicine is required to analyze a minimum of 5,000 tumor samples annually and delivers next-generation sequencing panels, comprehensive genomic profiling, and diagnostic tests for both solid and hematological malignancies across VA medical centers nationwide. Representative delivery orders under this vehicle include a $24.0 million base-year task order awarded October 2024 for comprehensive genomic profiling, a September 2025 modification adding Foundation Medicine International as an additional point of contact with expanded reporting requirements, and a $2,500 minimum-guaranteed-amount task order. Regionally distributed Veterans Integrated Service Networks (VISN 10, VISN 15, VISN 5, VISN 17, and others) account for the remaining 44 awards totaling roughly $747 thousand in combined potential value, consisting of small-dollar purchase orders and delivery orders for hematologic malignancies testing, reference laboratory services, and genomic testing to support local VA hospital oncology programs across Cleveland, Indianapolis, Cambridge, Shreveport, Philadelphia, and other locations. The Navy's Bureau of Medicine and Surgery has placed five awards worth $17 thousand for specialized testing services. The portfolio spans 61 total awards with $621.5 million in combined potential value, of which $157.9 million (25%) has been obligated to date.
Activity has contracted significantly in recent years — six awards in 2022, one in 2023, four in 2024, two in 2025, and one in 2026 — reflecting the dominance of the large single-award IDC, which generates delivery orders periodically rather than new competitive awards. Only three awards with combined potential value of $350 thousand face ultimate completion inside the next twenty-four months, indicating minimal recompete pressure in the near term beyond the existing VA contract's natural order cycles. SCI-reportable invoiced revenue totaled $20.4 million in FY2023 and zero in FY2022 and FY2024; the SCI dataset captured only four prime records with zero FTEs reported, reflecting that most Foundation Medicine work for VA is performed through fixed-price delivery orders against the large IDC rather than through hourly labor arrangements captured in Service Contract Inventory. Foundation Medicine operates as a parent company with 18 named subsidiaries, including Roche Diagnostics Corporation, Genentech Inc., Kapa Biosystems Inc., and Intermune Inc. (a self-certified small disadvantaged business), signaling vertical integration in molecular diagnostics, life sciences manufacturing, and precision oncology capabilities that support the core federal testing mission.
Quick answers
What is Foundation Medicine, Inc.'s UEI?
Foundation Medicine, Inc.'s Unique Entity ID (UEI) in SAM.gov is EHXPZ92G4AD1.
What is Foundation Medicine, Inc.'s CAGE code?
Foundation Medicine, Inc.'s CAGE code is 73CG0.
What is Foundation Medicine, Inc.'s primary NAICS code?
Foundation Medicine, Inc.'s primary NAICS code is 621511 (Medical Laboratories).
Where is Foundation Medicine, Inc. located?
Foundation Medicine, Inc.'s physical address in SAM.gov is 400 Summer St, Boston, MA 02210, USA.
Is Foundation Medicine, Inc. registered in SAM.gov?
Yes. Foundation Medicine, Inc.'s SAM.gov registration is active through April 8, 2027.
What is Foundation Medicine, Inc.'s most recent federal award?
Foundation Medicine, Inc.'s most recent federal contract award is Hematologic malignancies testing (36C25026C0159), from Veterans Integrated Service Network 10, on September 23, 2026.
On GovTribe
See Foundation Medicine, Inc.'s full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Federal grant awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors